Holen Sie sich die Stockscreener-App
1.27
5.22%
-0.07
Vorhandelsmarkt:
1.29
0.02
+1.57%
Schlusskurs vom Vortag:
$1.34
Offen:
$1.323
24-Stunden-Volumen:
340.38K
Relative Volume:
1.32
Marktkapitalisierung:
$65.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-51.47M
KGV:
-1.27
EPS:
-1
Netto-Cashflow:
$-47.50M
1W Leistung:
-4.51%
1M Leistung:
+16.51%
6M Leistung:
-3.79%
1J Leistung:
-19.62%
1-Tages-Spanne:
$1.27
$1.34
1-Wochen-Bereich:
$1.27
$1.35
52-Wochen-Spanne:
$0.81
$1.82
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Firmenname
Pmv Pharmaceuticals Inc
Sektor
Branche
Telefon
(609) 642-6670
Adresse
400 ALEXANDER PARK DRIVE, PRINCETON
Vergleichen Sie PMVP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.27 | 69.10M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-05-13 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-12 | Eingeleitet | Jefferies | Buy |
| 2023-12-27 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-22 | Hochstufung | Goldman | Neutral → Buy |
| 2021-08-19 | Eingeleitet | Oppenheimer | Perform |
| 2021-08-02 | Eingeleitet | Guggenheim | Buy |
| 2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-10-20 | Eingeleitet | Cowen | Outperform |
| 2020-10-20 | Eingeleitet | Evercore ISI | Outperform |
| 2020-10-20 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Pmv Pharmaceuticals Inc Aktie (PMVP) Neueste Nachrichten
Is PMV Pharmaceuticals Inc. a good long term investmentExceptional market performance - jammulinksnews.com
PMV Pharmaceuticals Inc. Stock Analysis and ForecastOver 200% growth - jammulinksnews.com
CHSN Stock Analysis and ForecastFree Trading Psychology Coaching - jammulinksnews.com
What analysts say about Advantage Solutions Inc. stockMassive wealth growth - jammulinksnews.com
What analysts say about PMV Pharmaceuticals Inc. stockExplosive trading opportunities - jammulinksnews.com
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionFree Financial Group - Newser
How PMV Pharmaceuticals Inc. stock performs during market volatilityMassive Upside Selection - Newser
Exploring India’s Stock Market through ETFs and Mutual Funds Consistent Stock Market ReturnsUnmatched profit potential - PrintWeekIndia
What drives Assurant Inc. stock priceMarket-beating performance - printweek.in
Benares Hotels Limited (509438) to Launch New Product LineSuperior returns - jammulinksnews.com
Is Red River Bancshares Inc. a good long term investmentDynamic investment growth - jammulinksnews.com
Best Stocks for Long Term Capital Appreciation in India Expert Selected High Growth StocksFree Consultation - Autocar Professional
What drives PMV Pharmaceuticals Inc. stock priceSuperior capital gains - Autocar Professional
What drives ATLCP stock priceTremendous wealth creation - jammulinksnews.com
Top Green Stocks to Buy Expert Verified Trading AlertsAccelerated profit realization - jammulinksnews.com
P 500 Structured Alt Protection Etf February stock priceTriple-digit profit margins - jammulinksnews.com
What analysts say about Big 5 Sporting Goods Corporation stockFree Stock Market Trend Analysis - jammulinksnews.com
Is Lesaka Technologies Inc. a good long term investmentRapid portfolio appreciation - jammulinksnews.com
Is Zynex Inc. a good long term investmentExceptional stock performance - jammulinksnews.com
KILO(kiloex) Price TodayCapital Growth Picks - Newser
BLID(bolide) Project ReviewFree Stock Market Analysis Courses - Newser
What analysts say about PMV Pharmaceuticals Inc. stock outlook5x Profit Potential - Newser
How High Can MVX(metavault trade) GoFree Exclusive Stock Market Insights - Newser
Real time deep learning model training with quantum cloud solutionsReal Trader Insights - Newser
Is KCS(kcs) a Good InvestmentFree Access to Group - Newser
How Ribbon Acquisition Corp. stock performs during market volatilityChart Based Entries - Newser
What makes PMV Pharmaceuticals Inc. stock price move sharplyFree Real-Time Stock Data - Newser
What makes Easterly Government Properties Inc. stock price move sharplyFree Market Sentiment Analysis - Newser
FISH(tonfish)Free Access to Investment Community - Newser
How First Guaranty Bancshares Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser
What makes ATLC stock price move sharplyTrend Based Entry Alerts - Newser
What makes RF.PRE stock price move sharplyFree Best Stocks to Buy Today - Newser
What makes Southern States Bancshares Inc. stock price move sharplyWeekly Double Return List - Newser
Why CDZI stock attracts strong analyst attentionFree Access to Group - Newser
How NNAVW stock performs during market volatilityRisk Adjusted Stock Signals - Newser
What makes SVCC stock price move sharplyTrade With Low Risk Exposure - Newser
Why AMREP Corporation stock attracts strong analyst attentionFree Investment Group - Newser
What makes VITL stock price move sharplyDefensive Stock Picks with Upside - Newser
Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pmv Pharmaceuticals Inc-Aktie (PMVP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jalota Deepika | Chief Development Officer |
Jul 01 '25 |
Sale |
1.06 |
33,065 |
35,198 |
89,959 |
| Carulli Michael | Chief Financial Officer |
Jul 01 '25 |
Sale |
1.06 |
28,249 |
30,077 |
60,146 |
| Mack David Henry | President and CEO |
Jul 01 '25 |
Sale |
1.06 |
58,411 |
62,179 |
536,133 |
| Mack David Henry | President and CEO |
Dec 03 '24 |
Option Exercise |
0.53 |
91,750 |
48,628 |
534,210 |
| Mack David Henry | President and CEO |
Jan 03 '25 |
Option Exercise |
0.53 |
17,709 |
9,386 |
551,919 |
| Jalota Deepika | Chief Development Officer |
Sep 11 '24 |
Sale |
1.50 |
7,218 |
10,853 |
118,283 |
| Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):